Exciting milestone for Sonder Capital portfolio company, Neptune Medical! Neptune Medical announced positive results from its 50-patient first-in-human CARE 1 study for the Triton Robotic Endoscopy System, demonstrating: • 0 adverse events • 100% cecal intubation and procedure completion • Strong adenoma and polyp detection rates • Improved ergonomics for physicians performing colonoscopies A major step forward in advancing robotic endoscopy and improving colorectal cancer screening. Congratulations to the Neptune team on this important achievement! Read more here: https://lnkd.in/g7UZFNwT
Sonder Capital
Venture Capital and Private Equity Principals
San Carlos, CA 2,158 followers
Committed to creating a new standard of care.
About us
Investing in life-changing healthcare technologies.
- Website
-
http://www.sondercapital.com
External link for Sonder Capital
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 2-10 employees
- Headquarters
- San Carlos, CA
- Type
- Partnership
- Founded
- 2019
Locations
-
Primary
Get directions
San Carlos, CA, US
Employees at Sonder Capital
Updates
-
Proud to support the SquareMind team on this journey. What they're building has the potential to fundamentally improve how skin exams are conducted - making them faster, more consistent, and more accessible for both physicians and patients. Excited to see Ali Khachlouf and the team bring Swan to market!
A meaningful step forward for dermatologists and for patients. We are announcing $18M in combined financing to bring Swan to market - starting in France, then the US, including our Series A led by Bpifrance and Sonder Capital, a US fund co-founded by Fred Moll, with the participation of Adamed Technology, Calm/Storm, Teampact.ventures and great business angels. We believe Swan can become a generational solution for physicians, supporting skin exams through full-body dermoscopy automated in just a few minutes. We build with physicians, for physicians - the everyday heroes - with the goal of making their lives easier while making high-quality skin exams efficient and accessible. Thank you 🙏 - to the dermatologists who have supported us from the start, - to the team for building and refining, every single day, - to our investors for backing us, - to our partners who contribute in so many ways. It’s a truly collective endeavour, and we’re still Day 1. Back to work. PS- Speaking of collective endeavour, we’re hiring 😊 This includes senior engineering roles across C++ (R&D), computer vision, and fullstack web. If you’re interested, please reach out. Kate Garrett Jay Watkins Frederic Moll Deborah K. Ori Belson, MD Amélie MAILLON Eva Clerc Paul Floquet Marcin Szczecinski Lucanus ⛵️ Polagnoli Romain Vidal Alban Oudin Fabrice Romano 🚀François de La Villardiere Nathalie Balla Henri HUGEDE Tanguy Serrat Wouter Wolfslag Kateryna Zorina Etienne Ricouard Gilles LAURENT Thierry Lefevre Jean-Jules B. Sébastien Combrexelle Sébastien Morel Clément Laguerre Aymeric Quesne Arthur Van der Veken Antoine Zins Hugo Serrat Caroline Bergaud Marc Bataillon PELOUZE F. Wadim de Boon Ernest Tom Loumaye Mathieu Martinot-Dubary
-
We’re proud to announce the closing of Sonder Capital’s second fund, Sonder Futures II—with participation from leading healthcare systems, including Mayo Clinic and Sutter Health. This milestone goes beyond capital. By bringing health systems directly into our ecosystem, we’re pairing founders with real-world clinical insight, faster pathways to adoption, and partners who are deeply aligned with the future of care delivery. With Futures II, we’re doubling down on our conviction in AI-enabled medical robotics and minimally invasive therapies—areas poised to redefine where, how, and by whom care is delivered. We believe the next generation of healthcare companies will be built with providers, not just for them—and we’re excited to help make that a reality. Grateful to our LPs, founders, and partners for the continued trust. Read more: https://lnkd.in/gmeGPhm5
-
We’re excited to be featured in the January 2026 issue of The Lens Magazine, by LSI — highlighting the people behind the work that drives medtech forward. At Sonder Capital, our Deal Team — Deborah K., Kate Garrett, Frederic Moll, and Jay Watkins — brings more than capital to the table. They bring operator experience, pattern recognition, and a relentless focus on building companies that matter. From first meeting to scale, they partner closely with founders to navigate complexity, accelerate development, and ultimately deliver technologies that change patient outcomes. Proud to see their perspective featured alongside other leaders shaping the future of healthcare! 📖 Preview the full issue here: bit.ly/41LsAKE #Medtech #HealthcareInnovation #VentureCapital #SonderCapital #TheLens #LSI
-
Huge congratulations to the Vitestro team on closing their Series B! Sonder Capital is proud to back a company redefining one of healthcare's most common procedures with autonomous robotic phlebotomy. Vitestro is building technology that can meaningfully improve access, consistency, and efficiency across care settings. Excited for what's ahead as the team continues scaling!
𝗪𝗲 𝗰𝗹𝗼𝘀𝗲𝗱 𝗮𝗻 𝗼𝘃𝗲𝗿𝘀𝘂𝗯𝘀𝗰𝗿𝗶𝗯𝗲𝗱 𝗦𝗲𝗿𝗶𝗲𝘀 𝗕 𝗼𝗳 $𝟳𝟬𝗠 🎉 We’re proud to welcome new strategic investment from Labcorp Venture Fund, Mayo Clinic, Sutter Health, InterVest Co., LTD, MGFO Private Investments, PGGM, Puma Venture Capital, and ROM Utrecht Region invest alongside existing investors Invest-NL, EIC - European Innovation Council Fund, Frederic Moll, NYBC Ventures, and Sonder Capital. “To close this financing reflects strong conviction in our mission to set a new standard in autonomous diagnostic blood collection.” Toon Overbeeke, CEO Read the full press release: https://lnkd.in/eVWn__P7 #SeriesB #MedTech #AutonomousPhlebotomy #Vitestro #Fundraising
-
-
What does it really take to navigate the investment world as an entrepreneur, CEO, and investor? Our partners Kate Garrett and Deborah K. joined Swaril Mathur on the Medtech Talk podcast to share candid insights from their journeys—what they’ve learned building companies, leading teams, and backing the next generation of innovators in medtech. If you’re building, investing, or just curious about what happens behind the scenes of venture and leadership, this conversation is worth a listen. 🎧 Listen on Apple Podcasts: https://lnkd.in/gv3EyH29 💡 Or on Medtech MVP: https://lnkd.in/eEz6BrC3 #Medtech #VentureCapital #Entrepreneurship #Leadership #WomenInVC #Podcast
-
-
We love partnering with our clinical colleagues on healthcare innovation. Looking forward to having this great discussion with the Mayo Clinic team and Auriel August, MD at LSI in March! #LSIUSA26
New LSI USA ‘26 Panel Just Announced — Mayo Clinic Invitation: Let’s Build the Future of Healthcare Mayo Clinic has long been a destination for breakthrough healthcare innovation, bringing together clinicians, engineers, researchers, and industry partners to solve some of medicine’s most complex challenges. This discussion will explore how Mayo Clinic identifies promising technologies, collaborates with startups, and accelerates solutions that can transform patient care. Panelists will share how innovators can engage with Mayo Clinic, what the institution looks for in potential partners, and how clinical insight and aligned collaboration can shape the next generation of healthcare. In this panel, you’ll hear perspectives from: • Peter Noseworthy, MD — Professor of Medicine, Cardiac Electrophysiologist, Department of Cardiovascular Diseases, Mayo Clinic • Auriel August, MD — Principal, SANTÉ Ventures • Nir G. — Director, Technology Development, Mayo Clinic • Kate Garrett — Managing Partner, Sonder Capital Want to get involved at LSI USA ‘26? Registration, presenter applications, and sponsorship opportunities are still available. Visit our website to secure your spot today for LSI USA ‘26 on March 16-20 in Dana Point, California. #LSIUSA26
-
-
We're excited to share this Forbes article by Amy Feldman highlighting Frederic Moll's remarkable career in healthcare innovation and his extraordinary impact on the lives of millions of patients year after year. At Sonder Capital, Fred’s vision aligns directly with our mission: to invest in bold, transformative healthcare technologies that have the power to reshape clinical care globally. We’re honored to support and learn from his leadership — and excited for what’s next. 🔗Read more here: https://lnkd.in/g9hzDx5D
-
Big congratulations to the Jupiter Endovascular team! 🎉 We’re thrilled to share that Jupiter Endovascular has closed an oversubscribed Series B, surpassing its $40M target — a huge milestone for this incredible team transforming endovascular care. The round was led by Sonder Capital, with Partner and Jupiter Board Member, Deborah K., leading our efforts. Jupiter’s breakthrough TFX platform is redefining precision, control, and reach in endovascular procedures — and we couldn’t be more excited for what’s ahead. Here’s to pushing the boundaries of innovation in vascular medicine together! 🚀 🔗 Read more here: https://lnkd.in/g92XN8jJ
-
The Sonder Capital team had an wonderful time co-hosting a gathering of diverse investors from around the world this week at the Hotel du Cap-Eden-Roc with Ashmoret Mishal 🎗️and The Family Offices Global. A big thank you to Ash and her team for organizing such a great event!
We were honored to host our exclusive French Riviera Family Offices Luncheon at the iconic Hotel du Cap-Eden-Roc, featuring a remarkable conversation with Dr. Frederic Moll — widely regarded as the father of robotic surgery and founder of both Intuitive Surgical and Auris. Joined by the visionary team at Sonder Capital — including Kate Garrett, a serial medtech entrepreneur and Stanford Biodesign faculty member, and Colby Wood, a leading healthcare investor — we explored how this group is reshaping the future of surgical innovation and unlocking transformative outcomes for patients and investors alike.
-